scholarly journals Work Productivity and Economic Burden of Systemic Sclerosis in a Multi‐Ethnic Asian Population

2020 ◽  
Author(s):  
Ling Xiang ◽  
Sandra MY Kua ◽  
Andrea HL Low
Keyword(s):  
Systemic Sclerosis ◽  
Economic Burden ◽  
Work Productivity ◽  
Asian Population

scholarly journals Work productivity in systemic sclerosis, its economic burden and association with health-related quality of life

Rheumatology ◽  
2017 ◽  
Vol 57 (1) ◽  
pp. 73-83 ◽  
Author(s):  
Kathleen Morrisroe ◽  
Vijaya Sudararajan ◽  
Wendy Stevens ◽  
Joanne Sahhar ◽  
Jane Zochling ◽  
...  
Keyword(s):  
Quality Of Life ◽  
Systemic Sclerosis ◽  
Economic Burden ◽  
Work Productivity ◽  
Health Related Quality ◽  
Related Quality ◽  
Health Related

The economic burden of systemic sclerosis—A systematic review

2021 ◽  
Author(s):  
Yongcong Chen ◽  
Lin Wu ◽  
Jose J. Hernández‐Muñoz ◽  
Michael J. Miller ◽  
Melinda Pope ◽  
...  
Keyword(s):  
Systematic Review ◽  
Systemic Sclerosis ◽  
Economic Burden

scholarly journals The economic burden of systemic sclerosis related pulmonary arterial hypertension in Australia

2019 ◽  
Vol 19 (1) ◽  
Author(s):  
Kathleen Morrisroe ◽  
Wendy Stevens ◽  
Joanne Sahhar ◽  
Gene-Siew Ngian ◽  
Nava Ferdowsi ◽  
...  
Keyword(s):  
Systemic Sclerosis ◽  
Pulmonary Arterial Hypertension ◽  
Arterial Hypertension ◽  
Economic Burden ◽  
Pulmonary Arterial

scholarly journals Understanding the Economic Burden of Nonsevere Nocturnal Hypoglycemic Events: Impact on Work Productivity, Disease Management, and Resource Utilization

2013 ◽  
Vol 16 (8) ◽  
pp. 1140-1149 ◽  
Author(s):  
Meryl Brod ◽  
Michael Wolden ◽  
Torsten Christensen ◽  
Donald M. Bushnell
Keyword(s):  
Disease Management ◽  
Resource Utilization ◽  
Economic Burden ◽  
Work Productivity

Indirect costs attributed to headache: A nation-wide survey of an active working population

Cephalalgia ◽  
2021 ◽  
pp. 033310242110437
Author(s):  
Raquel Gil-Gouveia ◽  
Raquel Miranda
Keyword(s):  
Economic Burden ◽  
Migraine Headache ◽  
Productivity Loss ◽  
Work Productivity ◽  
Indirect Costs ◽  
Headache Disorder ◽  
Point Prevalence ◽  
Work Loss ◽  
Convenience Sample ◽  
Nation Wide Survey

Background The economic burden of headache in European countries is substantial, mostly related to indirect work-productivity loss costs, yet data for Portugal is scarce. Methods An anonymous web-based survey of headache was distributed to a convenience sample of Portuguese companies’ workforces, to assess last-year headache and “yesterday”-point prevalence. Preexisting headaches were classified into migraine and non-migraine headache and work impact (absenteeism and presenteeism) was evaluated in relation to point prevalence. If no significant selection biases were detected, projected work-loss costs for the whole country were to be calculated. Results Eleven (17%) of 65 invited companies participated, around 15,000 active workers were exposed to the survey and 3624 (24.3%) responded, 73% females, 84.3% with previous (“last-year”) headaches, 53% with migraine. Due to participation and gender bias, national cost-projections were not calculated. Workday point-prevalence was 21% (migraine) and 9% (non-migraine headache), resulting in 14 employees with migraine losing, on average, 4 h and 32 min of work time. Presenteeism occurred in 29% of migraine and 15% of NMH employees. Yearly cost of each employee with a headache disorder was €664.88. Discussion Headache has a significant economic burden, as measured by work loss costs, in Portugal. Company-based interventions should aim to support employees’ access to headache diagnosis and treatment, including non-pharmacological coping strategies, in order to reduce headache related economic costs.

scholarly journals Employment status and socio-economic burden in systemic sclerosis: a cross-sectional survey

Rheumatology ◽  
2010 ◽  
Vol 49 (5) ◽  
pp. 982-989 ◽  
Author(s):  
C. Nguyen ◽  
S. Poiraudeau ◽  
C. Mestre-Stanislas ◽  
F. Rannou ◽  
A. Berezne ◽  
...  
Keyword(s):  
Systemic Sclerosis ◽  
Economic Burden ◽  
Employment Status ◽  
Cross Sectional Survey ◽  
Cross Sectional

Health care utilisation and economic burden of difficult-to-treat rheumatoid arthritis: a cost-of-illness study

Rheumatology ◽  
2021 ◽  
Author(s):  
Nadia M T Roodenrijs ◽  
Paco M J Welsing ◽  
Marlies C van der Goes ◽  
Janneke Tekstra ◽  
Floris P J G Lafeber ◽  
...  
Keyword(s):  
Rheumatoid Arthritis ◽  
Health Care ◽  
Resource Use ◽  
Economic Burden ◽  
Linear Regression Analysis ◽  
Work Productivity ◽  
Health Care Utilisation ◽  
Care Utilisation ◽  
Annual Total ◽  
The Impact

Abstract Objectives To determine the impact of difficult-to-treat rheumatoid arthritis (D2T RA) on (costs related to) health care utilisation, other resource use and work productivity. Methods Data regarding health care utilisation, other resource use and work productivity of 52 D2T (according to the EULAR definition) and 100 non-D2T RA patients were collected via a questionnaire and an electronic patient record review during a study visit. Annual costs were calculated and compared between groups. Multivariable linear regression analysis was performed to assess whether having D2T RA was associated with higher costs. Results Mean (95% confidence interval) annual total costs were €37,605 (€27,689-50,378) for D2T and €19,217 (€15,647-22,945) for non-D2T RA patients (p < 0.001). D2T RA patients visited their rheumatologist more frequently, were more often admitted to day care facilities, underwent more laboratory tests and used more drugs (specifically tsDMARDs), compared with non-D2T RA patients (p < 0.01). In D2T RA patients, the main contributors to total costs were informal help of family and friends (28%), drugs (26%) and loss of work productivity (16%). After adjustment for physical functioning (health assessment questionnaire (HAQ)), having D2T RA was no longer statistically significantly associated with higher total costs. HAQ was the only independent determinant of higher costs in multivariable analysis. Conclusions The economic burden of D2T RA is significantly higher than that of non-D2T RA, indicated by higher health care utilisation and higher annual total costs. Functional disability is a key determinant of higher costs in RA.

scholarly journals Evaluation of a new multi-parallel line immunoassay for systemic sclerosis-associated antibodies in an Asian population

Rheumatology ◽  
2012 ◽  
Vol 51 (8) ◽  
pp. 1465-1470 ◽  
Author(s):  
A. H. L. Low ◽  
S. Wong ◽  
J. Thumboo ◽  
S. C. Ng ◽  
J. Y. Lim ◽  
...  
Keyword(s):  
Systemic Sclerosis ◽  
Asian Population ◽  
Parallel Line
Sign in / Sign up

Export Citation Format

Share Document